Stoke Therapeutics Shares Are Trading Higher on Possible Continued Strength Following Q3 Reported Financial Results Yesterday. Also, Needham and HC Wainwright & Co. Reiterated Buy Ratings on the Stock.
Stoke Therapeutics Shares Are Trading Higher on Possible Continued Strength Following Q3 Reported Financial Results Yesterday. Also, Needham and HC Wainwright & Co. Reiterated Buy Ratings on the Stock.
stoke therapeutics股票交易較高,可能繼續保持強勢,昨日公佈了第三季度財務業績。此外,Needham和HC Wainwright & Co.重申了對該股的買入評級。
Stoke Therapeutics Shares Are Trading Higher on Possible Continued Strength Following Q3 Reported Financial Results Yesterday. Also, Needham and HC Wainwright & Co. Reiterated Buy Ratings on the Stock.
stoke therapeutics股票交易較高,可能繼續保持強勢,昨日公佈了第三季度財務業績。此外,Needham和HC Wainwright & Co.重申了對該股的買入評級。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。